- Home
- CELU vs APT Comparison
CELU vs APT Comparison
Compare CELU & APT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- APT
- Stock Information
- Founded
- CELU 2016
- APT 1983
- Country
- CELU United States
- APT Canada
- Employees
- CELU N/A
- APT N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- APT
- Sector
- CELU Health Care
- APT
- Exchange
- CELU Nasdaq
- APT Nasdaq
- Market Cap
- CELU 42.2M
- APT 50.5M
- IPO Year
- CELU N/A
- APT 1995
- Fundamental
- Price
- CELU $1.98
- APT $4.75
- Analyst Decision
- CELU
- APT
- Analyst Count
- CELU 0
- APT 0
- Target Price
- CELU N/A
- APT N/A
- AVG Volume (30 Days)
- CELU 75.0K
- APT 23.9K
- Earning Date
- CELU 05-08-2025
- APT 08-06-2025
- Dividend Yield
- CELU N/A
- APT N/A
- EPS Growth
- CELU N/A
- APT 2.28
- EPS
- CELU N/A
- APT 0.36
- Revenue
- CELU $54,220,000.00
- APT $58,180,000.00
- Revenue This Year
- CELU $23.29
- APT N/A
- Revenue Next Year
- CELU N/A
- APT N/A
- P/E Ratio
- CELU N/A
- APT $13.48
- Revenue Growth
- CELU 138.11
- APT N/A
- 52 Week Low
- CELU $1.00
- APT $4.06
- 52 Week High
- CELU $5.22
- APT $6.44
- Technical
- Relative Strength Index (RSI)
- CELU 51.94
- APT 50.46
- Support Level
- CELU $1.80
- APT $4.68
- Resistance Level
- CELU $2.26
- APT $4.95
- Average True Range (ATR)
- CELU 0.18
- APT 0.15
- MACD
- CELU 0.02
- APT 0.00
- Stochastic Oscillator
- CELU 48.25
- APT 36.61
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About APT Alpha Pro Tech Ltd.
Alpha Pro Tech Ltd is in the business of protecting people, products and environments. It is developing, manufacturing and marketing a line of disposable protective apparel and infection control products for the cleanroom, industrial, pharmaceutical, medical and dental markets. It also manufacture a line of building supply construction weatherization products that are sold under the Alpha Pro Tech brand name. The Company operates through two business segments: Building Supply and Disposable Protective Apparel. Key revenue is generated from Building Supply: consisting of a line of construction supply weatherization products. The construction supply weatherization products consist of housewrap and synthetic roof underlayment and synthetic roof underlayment accessories.